Inhibition of tumor xenograft growth in preclinical studies was first reported by selective inhibition of VEGF by use of anti-VEGF monoclonal antibodies and by VEGF receptor tyrosine kinase inhibitors (TKIs) [25]. The gene discussed is VEGFA; the disease is neoplasm.